Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-044028

SANGAMO THERAPEUTICS, INC · SGMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Edward O Lanphier II
Officer — President & CEO · Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 8, 2015A125,000$0.00A360,000D
Common StockF3,F2Dec 7, 2015F31,308$9.69D328,692D
Common StockF4Dec 7, 2015G13,000$0.00D1,172,521IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F5$9.41Dec 8, 2015A250,000D—Dec 7, 2025Common Stock250,000250,000D

Explanation of responses